Products & Therapies

Hepatobiliary & Pancreatic Products

 
CONTACT A REP

We’re committed to partnerships with interventional radiologists, pathologists, oncologists, surgeons, and the GI community for proactive GI care.

FEATURED PRODUCT

ACHIEVE MORE WITH EUS

Three interchangeable needles — the FNA, FNB, and FNF — allow for predictable biliary access, fine needle aspiration, fine needle biopsy, fiducial placement and improved procedural workflow in one procedure. 1-8

  • The six distal cutting edges of the SharkCore™ FNB needle are specifically designed to obtain cohesive units of tissue with intact cell architecture.9-11
  • The Beacon™ FNA needle, an interchangeable component of the Beacon™ EUS delivery system, is designed to improve tissue yield.1,12-13
  • The Beacon™  FNF  needle, pre-loaded with two solid gold markers, helps simplify the procedure, and reduces overall procedure time.14
Beacon EUS

SharkCore™ 
FNB Needle

SharkCore Needle

Beacon™
FNA Exchange System

Product image of the Beacon FNA needle

Beacon™
FNF Needle

Product image of the Beacon FNF needle

Leading Solutions for Thermal Ablation

For more than 40 years, Medtronic has been the world leader in designing and manufacturing advanced energy-based medical systems and accessories, such as Cool-tip™ E-Series radiofrequency ablation systems and the new Emprint™ HP Ablation system with Thermosphere™ technology.

Emprint™ HP Ablation System with Thermosphere™ Technology

The Emprint™ HP Ablation system enables a minimally invasive procedure with few side effects15, fast recovery time16,17, high accuracy18, and predictable margins.19

Emprint HP Ablation Generator with Thermosphere

Emprint™ HP Zone Chart app

Emprint App

The Emprint™ HP Ablation zone app puts the ablation setting details you need in the palm of your hand. With comprehensive ex vivo and in vivo ablation zone reference values, you can create tailored ablation zones20 with confidence.

Available for both Android and iPhone users.

Cool-tip™ RF Ablation System
E Series

What’s more powerful than having the right technology for soft-tissue ablation?

Be the first to deliver the power of choice in thermal ablation.

Emprint™ SX Ablation Platform with Thermosphere™ Technology

Barrx™
Radiofrequency Ablation System

The Barrx™ radiofrequency ablation system includes technology for treating Barrett's esophagus.21

Barrx Family

ARCHIMEDES™* Biodegradable Biliary and Pancreatic Stent

A new way of thinking about biliary drainage — procedural intervention should no longer be the norm.
ARCHIMEDES™* Biodegradable Biliary and Pancreatic Stent

CLINICAL & EDUCATION RESOURCES

We are committed to delivering educational solutions and resources aimed at helping you achieve procedural and clinical proficiency.

LEARN MORE

PATIENT RESOURCES

Find information about GI treatments and therapies.

FOLLOW US ON LinkedIn

Stay up to date with new products, innovative stories, and events.

Connect with us:

LinkedIn Gastrointestinal
1

TR110601 Rev 01 DV Report Dated November 11, 2011 (Data on file)

2

PPQ Report: TR-20009 Rev 01 dated March 9, 2015 (Data on File)

3

AA study report: TR-20003 Rev 01 dated March 18, 2015 (Data on file)

4

510k study TR100509 Rev 01 dated September 21, 2010 (Data on file).

5

AA study TR100706 Rev 01 dated January 6, 2011 (Data on file).

6

AA study TR110716 Rev 01 dated December 16, 2011 (Data on file).

7

DV/PPQ report: TR110601 Rev 01 dated November 11, 2011 (Data on file).

8

Based on internal testing data,V-0450-02 (Access DVT Report) dated February 8, 2019 (Data on file).

9

Internal test report #1085, July 8, 2014 and Internal test report #1090, September 25, 2014 (Data on file).

10

DiMaio CJ, Kolb JM, Benias PC, et al. Initial experience with a novel EUS-guided core biopsy needle (SharkCore™): results of a large North American multicenter study. Endosc Int Open. 2016;4(9):E974–E979.

11

Jovani M, Abidi WM, Lee LS. Novel fork-tip needles versus standard needles for EUS-guided tissue acquisition from solid masses of the upper GI tract: a matched cohort study. Scand J Gastroenterol. 2017;52(6–7):784–787.

12

Enestvedt B, Maranki, J, Makipour K, Mathur M, Haluszka O. Is two betterthan one? A comparison of EUS-FNA efficiency of single-vs multi-needle platforms. Gastrointest Endosc. 2013;77(5S):AB179.

13

Moore JZ, Zhang Q, McGill CS, et al. Modeling of the plane needle cutting edge rake and inclination angles for biopsy. J Manuf Sci Eng 2010;132:051005-1-051005-8.22b.

14

Kothari S, Kothari T, et al. 234, Endoscopic Ultrasound (EUS)-Guided Fiducial Placement for Stereotactic Body Radiotherapy (SBRT): First Global Experience with a New 22-Gauge “Pre-loaded” EUS Fiducial Needle The American Journal of Gastroenterology, vol 110, Supplement 1 October 2015

15

Chen MS, Li JQ, Zheng Y, et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006 Mar;243(3):321–328.

16

Hocquelet A, Balageas P, Laurent C, et al. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: A study of 281 Western patients. Int J Hyperthermia. 2015;31(7):749–757.

17

Zhang M. Ma H, Zhang J, He L, Ye X, Li X. Comparison of microwave ablation and hepatic resection for hepatocellular carcinoma: a meta analysis. Onco Targets Ther. 2017;10:4829–4839.

18

De Cobelli F, Marra P, Ratti F, et al. Microwave ablation of liver malignancies: comparison of effects and early outcomes of percutaneous and intraoperative approaches with different liver conditions. Med Oncol. 2017;34(4):49.

19

Vogl, TJ., Basten, LM., Nour-Eldin, A., Kaltenbach, B., Bodelle, B., Wichmann, JL., Ackermann, H., Naguib, NNN. Evaluation of microwave ablation of liver malignancy with enabled constant spatial energy control to achieve a predictable spherical ablation zones. Int J Hyperthermia. 2018 Jun;34(4):492-500. 

20

Internal memo RE00275376 Emprint vs Emprint HP Ablation Performance Comparison Memo, dated June 2020

21

Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic ablation of Barrett’s esophagus: a multicenter study with 2.5-year follow-up. Gastrointest Endosc. 2008;68:867-876.

 

ARCHIMEDES™* is property of AMG GI, a Q3 Medical Company

™* Third-party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.

CONTACT A REP

Speak with a Medtronic representative who can give you more information about GI products and therapies.

Contact a Rep